retatrutide clinical trials phase for weight loss: Study shows 30% body weight loss When will Retatrutide be available

[5] Van Hout MC, Hearne E

One can discern the very rare sarcomatoid variant of anaplastic large-cell lymphoma from malignant melanoma based on S100 negativity as well as its expression of CD30 and, focally, of epithelial membrane antigen

I have a couple of quick follow-up questions because I want to be respectful of your time

Real-world persistence is low: about half discontinue within a year and roughly three-quarters within two years , often due to cost or side effectsraising the risk of rebound weight and lost health gains (Scientific American on discontinuation rates)

In addition to acting on GLP-1 receptors, tirzepatide also targets GIP receptors located in the pancreas, adipose (fat) tissue, and brain regions involved in eating behavior and insulin regulation